By Jimmy Hoover ( January 4, 2016, 4:08 PM EST) -- Purdue Pharmaceutical urged a Federal Circuit panel Monday to reverse a New Jersey federal court's decision invalidating three sleep aid patents for being obvious in a dispute with Actavis Elizabeth, saying the patents used different dosages than other insomnia drugs did at the time....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.